Differential effects of short- and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats

European Journal of Neuroscience

Volumn 32, Issue 9, 2010, Pages 1516-1527

  Pirchl, Michael ^a   Ullrich, Celine ^a   Humpel, Christian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anti rat IgG; Cholinergic neurons; Homocysteine; Nerve growth factor; Sprague Dawley rats; Vascular

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; CHOLINE ACETYLTRANSFERASE; HOMOCYSTEINE; IMMUNOGLOBULIN G; LAMININ; NERVE GROWTH FACTOR; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD BRAIN BARRIER; BRAIN CORTEX; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DENSITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MAZE TEST; MEMORY DISORDER; MICROBLEEDING; NERVE FIBER; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SPATIAL MEMORY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINE; ANIMALS; BASAL NUCLEUS OF MEYNERT; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CHOLINE O-ACETYLTRANSFERASE; HEMORRHAGE; HYPERHOMOCYSTEINEMIA; LEARNING; MALE; MEMORY; NERVE GROWTH FACTORS; NEURONS; NEUROPSYCHOLOGICAL TESTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE CULTURE TECHNIQUES;

EID: 78149262357     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07434.x     Document Type: Article

References (87)

1. Andersson, A., Brattström, L., Israelsson, B., Isaksson, A., Hamfelt, A. & Hultberg, B. (1992) Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur. J. Clin. Invest., 22, 79-87.
2. Austin, R.C., Lentz, S.R. & Werstuck, G.H. (2004) Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ., 11, 56-64.
3. Baydas, G., Ozer, M., Yasar, A., Tuzcu, M. & Koz, S.T. (2005) Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in rats. Brain Res., 1046, 187-194.
4. Blasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J. & Humpel, C. (2006) Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement. Geriatr. Cogn. Disord., 21, 9-15.
5. Bostom, A.G., Rosenberg, I.H., Silbershatz, H., Jacques, P.F., Selhub, J., D'Agostino, R.B., Wilson, P.W. & Wolf, P.A. (1999) Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann. Intern. Med., 131, 352-355.
6. Böttger, D., Ullrich, C. & Humpel, C. (2010) Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neurons. Brain Res., 1312, 108-119.
7. Brattström, L., Lindgren, A., Israelsson, B., Andersson, A. & Hultberg, B. (1994) Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med., 236, 633-641.
8. Clarke, R., Smith, A.D., Jobst, K.A., Refsum, H., Sutton, L. & Ueland, P.M. (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol., 55, 1449-1455.
9. Counts, S.E. & Mufson, E.J. (2005) The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J. Neuropathol. Exp. Neurol., 64, 263-272.
10. Cuello, A.C., Bruno, M.A. & Bell, K.F. (2007) NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease. Curr. Alzheimer Res., 4, 351-358.
11. Darvesh, S., Walsh, R. & Martin, E. (2007) Homocysteine thiolactone and human cholinesterases. Cell. Mol. Neurobiol., 27, 33-48.
12. Dayal, S., Arning, E., Bottiglieri, T., Böger, R.H., Sigmund, C.D., Faraci, F.M. & Lentz, S.R. (2004) Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke, 35, 1957-1962.
13. Duan, W., Ladenheim, B., Cutler, R.G., Kruman, I.I., Cadet, J.L. & Mattson, M.P. (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J. Neurochem., 80, 101-110.
14. Durand, P., Prost, M., Loreau, N., Lussier-Cacan, S. & Blache, D. (2001) Impaired homocysteine metabolism and atherothrombotic disease. Lab. Invest., 81, 645-672.
15. Faraci, F.M. (2003) Hyperhomocysteinemia: a million ways to lose control. Arterioscler. Thromb. Vasc. Biol., 23, 371-373.
16. Fischer, W., Wictorin, K., Björklund, A., Williams, L.R., Varon, S. & Gage, F.H. (1987) Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature, 329, 65-68.
17. Fischer, H.P., Marksteiner, J., Ransmayr, G., Saria, A. & Humpel, C. (1998) NGF but not GDNF or neurturin enhance acetylcholine tissue levels in striatal organotypic brain slices. Int. J. Dev. Neurosci., 16, 391-401.
18. Flicker, L., Martins, R.N., Thomas, J., Acres, J., Taddei, K., Norman, P., Jamrozik, K. & Almeida, O.P. (2004) Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men. J. Alzheimers Dis., 6, 329-336.
19. Gallucci, M., Zanardo, A., De Valentin, L. & Vianello, A. (2004) Homocysteine in Alzheimer disease and vascular dementia. Arch. Gerontol. Geriatr. Suppl., 9, 195-200.
20. Garcia, A. & Zanibbi, K. (2004) Homocysteine and cognitive function in elderly people. CMAJ, 171, 897-904.
21. Glushchenko, A.V. & Jacobsen, D.W. (2007) Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. Antioxid. Redox Signal., 9, 1883-1898.
22. Gutiérrez, H., Miranda, M.I. & Bermúdez-Rattoni, F. (1997) Learning impairment and cholinergic deafferentation after cortical nerve growth factor deprivation. J. Neurosci., 17, 3796-3803.
23. Hasegawa, T., Ukai, W., Jo, D.G., Xu, X., Mattson, M.P., Nakagawa, M., Araki, W., Saito, T. & Yamada, T. (2005) Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease. J. Neurosci. Res., 80, 869-876.
24. Hernanz, A., Fernández-Vivancos, E., Montiel, C., Vazquez, J.J. & Arnalich, F. (2000) Changes in the intracellular homocysteine and glutathione content associated with aging. Life Sci., 67, 1317-1324.
25. Ho, P.I., Ortiz, D., Rogers, E. & Shea, T.B. (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res., 70, 694-702.
26. Hogervorst, E., Ribeiro, H.M., Molyneux, A., Budge, M. & Smith, A.D. (2002) Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch. Neurol., 59, 787-793.
27. Houze, P., Gamra, S., Madelaine, I., Bousquet, B. & Gourmel, B. (2001) Simultaneous determination of total plasma glutathione, homocysteine, cysteinylglycine, and methionine by high-performance liquid chromatography with electrochemical detection. J. Clin. Lab. Anal., 15, 144-153.
28. Humpel, C. & Marksteiner, J. (2005) Cerebrovascular damage as a cause for Alzheimer's disease. Curr. Neurovasc. Res., 2, 341-347.
29. Humpel, C. & Weis, C. (2002) Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices. Implication in Alzheimer's disease? J. Neural Transm. Suppl., 62, 253-263.
30. Jarrard, L.E., Okaichi, H., Steward, O. & Goldschmidt, R.B. (1984) On the role of hippocampal connections in the performance of place and cue tasks: comparisons with damage to hippocampus. Behav. Neurosci., 98, 946-954.
31. Kim, J.M., Lee, H. & Chang, N. (2002) Hyperhomocysteinemia due to short-term folate deprivation is related to electron microscopic changes in the rat brain. J. Nutr., 132, 3418-3421.
32. Kruman, I.I., Kumaravel, T.S., Lohani, A., Pedersen, W.A., Cutler, R.G., Kruman, Y., Haughey, N., Lee, J., Evans, M. & Mattson, M.P. (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci., 22, 1752-1762.
33. Lee, H., Kim, H.J., Kim, J.M. & Chang, N. (2004) Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia. Brain Res., 996, 139-147.
34. Lee, H., Kim, J.M., Kim, H.J., Lee, I. & Chang, N. (2005) Folic acid supplementation can reduce the endothelial damage in rat brain microvasculature due to hyperhomocysteinemia. J. Nutr., 135, 544-548.
35. Levi-Montalcini, R., Skaper, S.D., Dal Toso, R., Petrelli, L. & Leon, A. (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci., 19, 514-520.
36. Lipton, S.A., Kim, W.K., Choi, Y.B., Kumar, S., D'Emilia, D.M., Rayudu, P.V., Arnelle, D.R. & Stamler, J.S. (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA, 94, 5923-5928.
37. Lominadze, D., Roberts, A.M., Tyagi, N., Moshal, K.S. & Tyagi, S.C. (2006) Homocysteine causes cerebrovascular leakage in mice. Am. J. Physiol. Heart Circ. Physiol., 290, 1206-1213.
38. Luchsinger, J.A., Tang, M.X., Shea, S., Miller, J., Green, R. & Mayeux, R. (2004) Plasma homocysteine levels and risk of Alzheimer disease. Neurology, 62, 1972-1976.
39. Luo, Y., Zhou, X., Yang, X. & Wang, J. (2007) Homocysteine induces tau hyperphosphorylation in rats. Neuroreport, 18, 2005-2008.
40. Makhro, A.V., Mashkina, A.P., Solenaya, O.A., Trunova, O.A., Kozina, L.S., Arutyunian, A.V. & Bulygina, E.R. (2008) Prenatal hyperhomocysteinemia as a model of oxidative stress of the brain. Bull. Exp. Biol. Med., 146, 33-35.
41. Malaguarnera, M., Ferri, R., Bella, R., Alagona, G., Carnemolla, A. & Pennisi, G. (2004) Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. Clin. Chem. Lab. Med., 42, 1032-1035.
42. Marksteiner, J. & Humpel, C. (2008) Beta-amyloid expression, release and extracellular deposition in aged rat brain slices. Mol. Psychiatry, 13, 939-952.
43. Marksteiner, J., Kemmler, G., Weiss, E.M., Knaus, G., Ullrich, C., Mechteriakov, S., Oberbauer, H., Auffinger, S., Hinterhölzl, J., Hinterhuber, H. & Humpel, C. (2009) Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging, doi:.
44. McCaddon, A., Davies, G., Hudson, P., Tandy, S. & Cattell, H. (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry, 13, 235-239.
45. McIlroy, S.P., Dynan, K.B., Lawson, J.T., Patterson, C.C. & Passmore, A.P. (2002) Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke, 33, 2351-2356.
46. Medina, M., Urdiales, J.L. & Amores-Sánchez, M.I. (2001) Roles of homocysteine in cell metabolism: old and new functions. Eur. J. Biochem., 268, 3871-3882.
47. Miranda, M.I. & Bermúdez-Rattoni, F. (1999) Reversible inactivation of the nucleus basalis magnocellularis induces disruption of cortical acetylcholine release and acquisition, but not retrieval, of aversive memories. Proc. Natl. Acad. Sci. USA, 96, 6478-6482.
48. Moat, S.J., Lang, D., McDowell, I.F., Clarke, Z.L., Madhavan, A.K., Lewis, M.J. & Goodfellow, J. (2004) Folate, homocysteine, endothelial function and cardiovascular disease. J. Nutr. Biochem., 15, 64-79.
49. Morris, M.S. (2003) Homocysteine and Alzheimer's disease. Lancet Neurol., 2, 425-428.
50. Nagahara, A.H., Bernot, T., Moseanko, R., Brignolo, L., Blesch, A., Conner, J.M., Ramirez, A., Gasmi, M. & Tuszynski, M.H. (2009) Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery. Exp. Neurol., 215, 153-159.
51. Naumann, T., Kermer, P. & Frotscher, M. (1994) Fine structure of rat septohippocampal neurons. III. Recovery of choline acetyltransferase immunoreactivity after fimbria-fornix transection. J. Comp. Neurol., 350, 161-170.
52. Obeid, R. & Herrmann, W. (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett., 580, 2994-3005.
53. Obeid, R., McCaddon, A. & Herrmann, W. (2007) The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin. Chem. Lab. Med., 45, 1590-1606.
54. Pacheco-Quinto, J., Rodriguez de Turco, E.B., DeRosa, S., Howard, A., Cruz-Sanchez, F., Sambamurti, K., Refolo, L., Petanceska, S. & Pappolla, M.A. (2006) Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol. Dis., 22, 651-656.
55. Papatheodorou, L. & Weiss, N. (2007) Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal., 9, 1941-1958.
56. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press Inc., New York.
57. Perla-Kaján, J., Twardowski, T. & Jakubowski, H. (2007) Mechanisms of homocysteine toxicity in humans. Amino Acids, 32, 561-572.
58. Perry, I.J., Refsum, H., Morris, R.W., Ebrahim, S.B., Ueland, P.M. & Shaper, A.G. (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet, 346, 1395-1398.
59. Pirchl, M., Marksteiner, J. & Humpel, C. (2006) Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease. Neurol. Res., 28, 657-664.
60. Pirchl, M., Kemmler, G. & Humpel, C. (2010) Female Sprague Dawley rats show impaired spatial memory in the 8-arm radial maze under dim blue and red light. Int. J. Zool., Available at
61. Poddar, R., Sivasubramanian, N., DiBello, P.M., Robinson, K. & Jacobsen, D.W. (2001) Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic zendothelial cells: implications for vascular disease. Circulation, 103, 2717-2723.
62. Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Forloni, G., Tettamanti, M. & Lucca, U. (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr., 80, 114-122.
63. Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E. & Licastro, F. (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr., 82, 636-643.
64. Robert, K., Pagàs, C., Ledru, A., Delabar, J., Caboche, J. & Janel, N. (2005) Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience, 133, 925-935.
65. Sai, X., Kawamura, Y., Kokame, K., Yamaguchi, H., Shiraishi, H., Suzuki, R., Suzuki, T., Kawaichi, M., Miyata, T., Kitamura, T., De Strooper, B., Yanagisawa, K. & Komano, H. (2002) Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J. Biol. Chem., 277, 12915-12920.
66. Schmidt-Kastner, R., Meller, D., Bellander, B.M., Strömberg, I., Olson, L. & Ingvar, M. (1993) A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry. J. Neurosci. Methods, 46, 121-132.
67. Selhub, J. (1999) Homocysteine metabolism. Annu. Rev. Nutr., 19, 217-246.
68. Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F., Rosenberg, I.H., D'Agostino, R.B., Wilson, P.W. & Wolf, P.A. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med., 346, 476-483.
69. Shastry, S., Moning, L., Tyagi, N., Steed, M. & Tyagi, S.C. (2005) GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia. J. Cell. Physiol., 205, 422-427.
70. Shea, T.B., Lyons-Weiler, J. & Rogers, E. (2002) Homocysteine, folate deprivation and Alzheimer neuropathology. J. Alzheimers Dis., 4, 261-267.
71. Skurk, C. & Walsh, K. (2004) Death receptor induced apoptosis: a new mechanism of homocysteine-mediated endothelial cell cytotoxicity. Hypertension, 43, 1168-1170.
72. Sontag, E., Nunbhakdi-Craig, V., Sontag, J.M., Diaz-Arrastia, R., Ogris, E., Dayal, S., Lentz, S.R., Arning, E. & Bottiglieri, T. (2007) Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J. Neurosci., 27, 2751-2759.
73. Stefanello, F.M., Monteiro, S.C., Matté, C., Scherer, E.B., Netto, C.A. & Wyse, A.T. (2007) Hypermethioninemia increases cerebral acetylcholinesterase activity and impairs memory in rats. Neurochem. Res., 32, 1868-1874.
74. Streck, E.L., Bavaresco, C.S., Netto, C.A. & Wyse, A.T. (2004) Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav. Brain Res., 153, 377-381.
75. Thoenen, H., Zafra, F., Hengerer, B. & Lindholm, D. (1991) The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems. Ann. N.Y. Acad. Sci., 640, 86-90.
76. Troen, A.M. (2005) The central nervous system in animal models of hyperhomocysteinemia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 1140-1151.
77. Tyagi, S.C., Lominadze, D. & Roberts, A.M. (2005) Homocysteine in microvascular endothelial cell barrier permeability. Cell Biochem. Biophys., 43, 37-44.
78. Tyagi, N., Gillespie, W., Vacek, J.C., Sen, U., Tyagi, S.C. & Lominadze, D. (2009) Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. J. Cell. Physiol., 220, 257-266.
79. Wang, G. & O, K. (2001) Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals. Biochem. J., 357, 233-240.
80. Wang, G., Siow, Y.L. & O, K. (2000) Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem. J., 352, 817-826.
81. Weis, C., Marksteiner, J. & Humpel, C. (2001) Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert. Neuroscience, 102, 129-138.
82. Weiss, N., Zhang, Y.Y., Heydrick, S., Bierl, C. & Loscalzo, J. (2001) Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc. Natl. Acad. Sci. USA, 98, 12503-12508.
83. Zassler, B. & Humpel, C. (2006) Transplantation of NGF secreting primary monocytes counteracts NMDA-induced cell death of rat cholinergic neurons in vivo. Exp. Neurol., 198, 391-400.
84. Zassler, B., Weis, C. & Humpel, C. (2003) Tumor necrosis factor-alpha triggers cell death of sensitized potassium chloride-stimulated cholinergic neurons. Brain Res. Mol. Brain Res., 113, 78-85.
85. Zhang, F., Slungaard, A., Vercellotti, G.M. & Iadecola, C. (1998) Superoxide-dependent cerebrovascular effects of homocysteine. Am. J. Physiol., 274, 1704-1711.
86. Zhang, L., Jin, M., Hu, X.S. & Zhu, J.H. (2005) Homocysteine stimulates nuclear factor kappaB activity and interleukin-6 expression in rat vascular smooth muscle cells. Cell Biol. Int., 30, 592-597.
87. Zhang, C.E., Wei, W., Liu, Y.H., Peng, J.H., Tian, Q., Liu, G.P., Zhang, Y. & Wang, J.Z. (2009) Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol., 174, 1481-1491.